1. Anti-rotavirus effects by combination therapy of stevioside and Sophora flavescens extract.
- Author
-
Alfajaro, Mia Madel, Mun-Chual Rho, Hyun-Jeong Kim, Jun-Gyu Park, Deok-Song Kim, Hosmillo, Myra, Kyu-Yeol Son, Ju-Hwan Lee, Sang-Ik Park, Mun-Il Kang, Young Bae Ryu, Ki Hun Park, Hyun-Mee Oh, SeungWoong Lee, Su-Jin Park, Woo Song Lee, and Kyoung-Oh Cho
- Subjects
- *
ROTAVIRUS diseases , *SOPHORA , *STEVIOSIDE , *STEVIA rebaudiana , *IN vitro studies , *BODY weight - Abstract
Anti-rotaviral activities of Sophora flavescens extract (SFE) and stevioside (SV) from Stevia rebaudiana Bertoni either singly or in various combinationswere examined in vitro and in vivo using a porcine rotavirus G5[P7] strain. Combination of SFE and SV inhibited in vitro virus replication more efficiently than each single treatment. In the piglet model, SV had no effect on rotavirus enteritis, whereas SFE improved but did not completely cure rotaviral enteritis. Interestingly, combination therapy of SFE and SV alleviated diarrhea, and markedly improved small intestinal lesion score and fecal virus shedding. Acute toxicity tests including the piglet lethal dose 50, and body weight, organ weight and pathological changes for the combination therapy did not show any adverse effect on the piglets. These preliminary data suggest that the combination therapy of SV and SFE is a potential curative medication for rotaviral diarrhea in pigs. Determination of the efficacy of this combination therapy in other species including humans needs to be addressed in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF